Thyroid and neuroendocrine.

4 Phase 1 studies recruiting right now, most recently updated first.

Thyroid and neuroendocrine4 studies

Inoperable Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET)NCT04086485Papers

Lu-177-DOTATATE

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

National Cancer Institute (NCI)Open the brief

BRAF V600E Wild-Type Anaplastic Thyroid CancerNCT06902376

Neoadjuvant XL092 + Cemiplimab

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

UNC Lineberger Comprehensive Cancer CenterOpen the brief

Recurrent Differentiated Thyroid CancerNCT04892303

External Beam Radiation + Radioactive Iodine

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOpen the brief

Neuroendocrine CarcinomaNCT06889493

Seneca Valley Virus-001 (SVV-001)

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

Peter Hosein, MDOpen the brief